Use and performance of the evolut FX transcatheter aortic valve system
Tanvir Bajwa(Aurora Health Care), Gilbert H.L. Tang(Mount Sinai Health System), Hiram G. Bezerra, Matthew D. Saybolt(Jersey Shore University Medical Center), George Petrossian, Guilherme F. Attizzani(Université Claude Bernard Lyon 1), Mathew Williams(Mount Sinai Health System), Stanley Chetcuti(University of Michigan), Robert D. Jumper(St. Vincent's Medical Center), William Merhi(Corewell Health), Mustafa I. Ahmed(National and Kapodistrian University of Athens), L. Lambrecht(Medtronic (Ireland)), Willis Wu(Rex Hospital), Paul Mahoney(Sentara Norfolk General Hospital), Suhail Allaqaband, Robert Stoler(Baylor University Medical Center), Hemal Gada(University of Pittsburgh Medical Center)
Cited by 8
Related Papers
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k